Wandelnde Muster: Veränderungen des Erregerspektrums in der Pädiatrie

Die COVID-19-Pandemie hat nahezu jeden Aspekt der Gesellschaft tiefgreifend beeinflusst, u.a. auch die Epidemiologie von Infektionskrankheiten bei Kindern. Dieses Review verschafft einen Überblick über die sich wandelnden Erregerspektren mit den damit verbundenen klinischen Konsequenzen und gibt einen Ausblick auf die Zukunft.

Schlüsselwörter

COVID-19 - Pandemie - Infektionsprävention - Erregerspektrum - virale Atemwegsinfektionen - bakterielle Atemwegsinfektionen - RSV - Impfungen - Tuberkulose

• Literatur

• 1 GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis 2024; 24: 974-1002
• 2 GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2022; 400: 2221-2248
• 3 Stein RT, Zar HJ. RSV through the COVID-19 pandemic: Burden, shifting epidemiology, and implications for the future. Pediatr Pulmonol 2023; 58: 1631-1639
• 4 Silva-Costa C, Gomes-Silva J, Pinho M. et al. Rebound of pediatric invasive pneumococcal disease in Portugal after the COVID-19 pandemic was not associated with significant serotype changes. J Infect 2024; 89: 106242
• 5 Taha S, Deghmane AE, Taha MK. Recent increase in atypical presentations of invasive meningococcal disease in France. BMC Infect Dis 2024; 24: 640
• 6 Nanthan KR, Plantener E, Coia J. et al. Impact of COVID-19 Restrictions on Incidence of Enteropathogenic Bacteria, Virus, and Parasites in Denmark: A National, Register-Based Study. Microorganisms 2024; 12: 1224
• 7 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1081235/UKHSA-norovirus-bulletin-2021-to-2022-week-23.pdf
• 8 https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2022.pdf?__blob=publicationFile
• 9 Jacobsen S, Faber M, Altmann B. et al. Impact of the COVID-19 pandemic on norovirus circulation in Germany. Int J Med Microbiol 2024; 391
• 10 Treharne A, Patel Murthy B, Zell ER. et al. Impact of the COVID-19 pandemic on routine childhood vaccination in 9 U.S. jurisdictions. Vaccine 2024; 42: 125997
• 11 Centers for Disease Control and Prevention, Progress Toward Measles Elimination – Worldwide, 2000-222. https://www.cdc.gov/mmwr/volumes/72/wr/mm7246a3.htm?s_cid=mm7246a3_w
• 12 Surendra H, Elyazar IRF, Puspaningrum E. et al. Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: a nationwide longitudinal analysis of programme data. Lancet Glob Health 2023; 11: e1412-e1421
• 13 Assad Z, Romain AS, Aupiais C. et al. Nirsevimab and Hospitalization for RSV Bronchiolitis. N Engl J Med 2024; 391: 144-154
• 14 Kampmann B, Madhi SA, Munjal I. et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med 2023; 388: 1451-1464